300 N. Washington St., Suite 200, Falls Church, VA 22046, USA. Form 4 or Form 5 obligations may continue. . Abbey joined Dexcom in May of 2016. . ABBEY,DONALD, evp, 1 Jul 2019 - , branch DEXCOM, INC. (Hawaii (US), 12 Sep 2016 - ) Overall this makes us a bit cautious, but it's not the be all and end all. Sign up in seconds, it's free! Revenue $2.45B . Donald Abbey Executive Vice President, Quality and Information Technology at Dexcom, Inc. . Donald M. Abbey is the Exec. Abbey Donald Net Worth 2022 and insider trades. Jereme has made over 15 trades of the Dexcom Inc stock since 2017, according to the Form 4 filled with the SEC. Executive Vice President and Managing Director, Dexcom Ventures. Get information on the Dexcom CEO and leadership team - read bios, learn about Dexcom leadership diversity, and more . The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. Industry Medical Equipment/Supplies. The company's filing status is listed as Active and its File Number is 73170 F1. Donald Abbey. Services, IT, Quality & Regulatory Affairs at DexCom. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with . DXCM. ) Here are further demographic highlights of the leadership team: The Dexcom executive team is 25% female and 75% male. Executive Summary. Donald Abbey - Director - ICU Medical; Industry Colleagues. The expanded portfolio that includes Dexcom G6 and Dexcom G6 Pro in the U.S. and Dexcom G7 and Dexcom ONE 1 internationally, offers the most innovative, connected and accessible CGM options available for people living with diabetes around the world; The portfolio is built on the unparalleled accuracy of Dexcom CGM 2, accuracy that is supported by more peer reviewed research than any other CGM . Chairman, President & Chief Executive Officer. EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 9,766 shares of DXCM on 08/24/2020 at an average price of $424.66 a share. Prior to joining Dexcom, Mr. Abbey was with Becton Dickinson (who acquired CareFusion Corporation in 2015 and which was spun out of Cardinal Health in 2009 . . In the past he occupied the position of Senior Vice President-Quality & Regulatory at Becton, Dickinson & Co. and Executive VP-Regulatory & Medical Affairs at CareFusion Corp. (a subsidiary of Becton, Dickinson & Co.), Senior VP-Quality & Regulatory Affairs at Cardinal Health . DexCom, Inc. hat sich auf die Entwicklung, Herstellung und Vermarktung von Systemen zur kontinuierlichen Blutzuckermessung (CGM) fr Menschen mit Diabetes und Gesundheitsdienstleister spezialisiert. 8,32x. The Insider Trading Activity of Abbey Donald on Markets Insider. The Open Database Of The Corporate World. Phone 703.538.7600 - Fax 703.538.7676 - Toll free 888.838.5578 DexCom, Inc. insider trades are shown in the following chart. VP of Global Bus. Based on our data team's research, Kevin Ronald Sayer is the Dexcom's CEO. DEXCOM, INC. Dexcom, Inc. is a Hawaii Foreign Profit Corporation filed On September 12, 2016. Mr. Abbey owns over 1,263 units of Dexcom Inc stock worth over $23,937,386 and over the last 6 years he sold DXCM stock worth over $20,346,229. In total, Donald Abbey sold US$1.1m worth of shares in that time, and we didn't record any purchases whatsoever. DexCom Inc. 6340 Sequence Drive. Companies Officers . DexCom, Inc. sagte, dass es keine aktiven Fusionsgesprche gibt, was die Aktie um mehr als 8% ansteigen lie, nachdem letzte Woche berichtet wurde, dass das Unternehmen Gesprche ber den Kauf der. Company List - D; DXCM; Insider Trading activities at Dexcom Inc (DXCM) . See. Initially, upon joining Dexcom Mr. Abbey was Executive Vice President, Quality until January of 2017 when he was promoted to his current position. 6 300. Abbey joined Dexcom in May of 2016. Don assumed the role of Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs in January 2017, and previously served as Executive Vice President, Quality from May 2016 to January 2017. . Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. Table 1 shows the monthly insider trading data of Dexcom Inc.Table 2 shows the detailed insider transactions. DexCom, Inc. is a medical device manufacturing company. VP & MD of Dexcom Ventures Andrew K. Balo, DEXCOM, INC. : Cours de bourse, graphiques, cotations, conseils boursiers, donnes financires, analyses et actualits en temps rel de l'action DEXCOM, INC . DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. Dexcom Leadership. Abbey Donald (Last) (First) (Middle) 6340 SEQUENCE DRIVE (Street) SAN DIEGO CA 92121 (City) (State) (Zip) 2. The company offers its systems for use by people with . Get information on the Dexcom CEO and leadership team - read bios, learn about Dexcom leadership diversity, and more . 0. . In the past he occupied the position of Senior Vice President-Quality &. "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will . Read More. Linked companies : DexCom, Inc. - ICU Medical, Inc. Summary. ABBEY DONALD M . The company's principal address is C/O . Abbey Donald sec form 4 filings insider trading, insiders stock buying and selling. Donald Abbey: Executive Vice President, Quality and Regulatory Affairs: 2020-07-01: Quentin S. Blackford: Chief Operating Officer and . The Registered Agent on file for this company is Corporation Service Company and is located at 501 Louisiana Avenue, Baton Rouge, LA 70802. . . Real time insider trading transaction history: Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares. Donald Abbey. FORM 4. Pays de rsidence : Non renseign. Public asset : 25,955,641 USD. Check this box if no longer subject to Section 16. Mr. Andrew Balo . At DexCom, Don Abbey has 22 colleagues including Kevin Sayer (CEO & Chairman), Steve Altman (Director) Homonyms. Dexcom Inc is a incorporated in the state of Delaware. Donald M. Abbey EVP Quality Regulatory Affairs: $406.06 PER SHARE: 932 $378,448: Mar 9, 2022 Sale: Mr Patterson owns over 777 units of Dexcom Inc stock worth over $4,577,570 and over the last few years he sold DXCM stock worth over $1,302,720. Donald M. Abbey, Exec. DexCom, Inc. a dclar qu'il n'tait pas en pourparlers actifs pour une fusion, ce qui a fait grimper l'action de plus de 8 % aprs les informations de la semaine dernire selon lesquelles la . A vertical stack of three evenly spaced horizontal lines. execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director or both of DexCom, Inc. (the "Company"), Forms 3, 4 and 5 (and any amendments thereto) in accordance with Section 16(a) of the Exchange Act and the rules thereunder; 3. . It means DexCom issued new shares from Dec. 2021 to Mar. Donald Abbey: Executive VP, Divisional: Jereme . Press Release; 04/28/22; Press Release; Dexcom Reports First Quarter 2022 Financial Results. VP of Global Bus. . For financial reporting, their fiscal year ends on December 31st. Services, IT, Quality & Regulatory Affairs at DexCom. Fiscal Year-end 12/2022. Officer. EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 9,766 shares of DXCM on 08/24/2020 at an average price of $424.66 a share. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. . The Presence of Donald Abbey's profile does not indicate a business or promotional relationship of any kind between RelSci and Donald Abbey. EVP, Regulatory Strategy . See the company profile and updated insider trades of DEXCOM, INC. (DXCM). Donald Abbey. Information on Donald Abbey (vice president) Learn how to leverage transparent company data at scale. The estimated Net Worth of Donald Abbey is at least $47.2 Million dollars as of 9 September 2021. Age : 54. Insiders are officers, directors, or significant investors in a company. Shelly Selvaraj. Mehr Finanzkennziffern. Kevin Sayer. Dexcom's Chairman, President and Chief Executive Officer is Kevin Sayer. . Donald Abbey is Executive Vice President-Quality & Regulatory Affairs at DexCom, Inc. View Donald Abbey's professional profile on Relationship Science, the database of decision makers. Key People: Kevin Sayer, chair, president andCEO; Donald Abbey, EVP, quality and regulatory affairs; Andrew Balo, EVP, regulatory strategy, clinical affairs and strategic . Insider Trading - DEXCOM INC (. 2022 (98 Mil). Mitarbeiterzahl. Donald M. Abbey is the Exec. In the past he occupied the position of Senior Vice President-Quality &. DEXCOM INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. The Registered Agent on file for this company is Corporation Service Company and is located at 1003 Bishop Street Suite 1600 Pauahi Tower, Honolulu, HI 96813. . VP of Global Bus. Abbey Donald: officer: EVP Quality and Regulatory Aff: 3750 TORREY VIEW COURT SAN DIEGO CA 92130 . Does DexCom Boast High Insider Ownership? The estimated Net Worth of Chad Patterson is at least $5.88 Milion dollars as of 9 May 2022. DexCom, Inc. is a medical device company. Andrew Balo. Andrew Balo. See the company profile and updated insider trades of Dexcom Inc (DXCM). 2022 . Donald Abbey. Abbey Donald (Reporting) DexCom (Issuer) Form 4 Statement of changes in beneficial ownership of securities 03/02/2021 6:31 PM: DexCom (Issuer) Murphy Patrick Michael (Reporting) Form 4 Statement of changes in beneficial ownership of securities 02/26/2021 5:02 PM: DexCom (Issuer) Sylvain Jereme M (Reporting) Form 4 Donald M. Abbey. . Prior to joining Dexcom, Mr. Abbey was with Becton Dickinson (who . Donald Abbey. Initially, upon joining Dexcom Mr. Abbey was Executive Vice President, Quality until January of 2017 when he was promoted to his current position. . right-arrow. Other executives include Jake Leach, EVP, Chief Technology Officer; Jereme Sylvain, EVP, Chief Financial Officer and 20 others. San Diego-based Dexcom was founded in 1999. Directors. The Insider Trading Activity of Abbey Donald on Markets Insider. Donald M. Abbey is on the . The sprawling estate, once . Phone 1 858 200-0200. Donald Abbey was born in the United States of America, and is a businessman, best known for founding the real estate development and investment firm The Abbey Company in 1990. . Dexcom Inc is primarely in the business of surgical & medical instruments & apparatus. Kevin Sayer CHM (63) Jereme Sylvain CFO (41) Sadie Stern CHO (46) Jacob Leach EVP (43) Donald Abbey EVP (54) Andrew Balo EVP (73) Its first approved CGM, a three-day sensor, received an FDA nod in 2006 and the company has continued to develop since. Services, IT, Quality & Regulatory Affairs at DexCom. Donald ("Don") Abbey is Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs. Patrimoine public : 25 955 641 USD. Steven Pacelli. 2022 was 98 Mil. Donald M. Abbey EVP Quality Regulatory Affairs: 1180: Disposition at . Overview; Reviews; About; Leadership; Review Dexcom. The Investor Relations website contains information about DexCom, Inc.'s business for stockholders, potential investors, and financial analysts. DONALD M. ABBEY Signature Donald M. Abbey Printed Name . Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. In the Medical Equipment industry, Don Abbey has 9,714 colleagues in 955 companies located in 49 countries. Dexcom CEO and Executives. DEXCOM, INC. Dexcom, Inc. is a Hawaii Foreign Profit Corporation filed On September 12, 2016. 3,443 executive movements have been recorded in the last 12 . 2 . Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc (DXCM) since 2005 are shown in Table 1 and Table 2. SEC Form 4. Overview; Reviews; About; Leadership; Review Dexcom. Donald M. Abbey is the Exec. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP Quality and Regulatory Aff 3. DEXCOM INC: 03/08/2022 1,180 406.06 Sell No DEXCOM INC: 03/08/2022 . The company's filing status is listed as Active and its File Number is 40307384F. Principales socits : DexCom, Inc. - ICU Medical, Inc. Synthse. Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. . In addition, he makes $2,919,160 as Executive Vice President - Quality and Regulatory Affairs at Dexcom Inc. 64% of the management team is White. Its other products include Dexcom ONE and Dexcom G7. . Kevin Sayer. EVP, Global Business Services, IT, Quality and Regulatory Affairs. 99,5%. Most recently he sold 3,000 units of DXCM stock worth $1,229,310 on 15 March 2022. . BURNABY, British Columbia-- (BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with type 1 and type 2 diabetes age two and over on multiple daily injections of insulin (three or more) or who use an insulin pump may now be eligible for public coverage of . A vertical stack of three evenly spaced horizontal lines. EVP, Quality and Regulatory Affairs. . Issuer Name and Ticker or Trading Symbol DEXCOM INC [ DXCM] 5. Age : 54. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with . . Press . DexCom's quarterly shares outstanding increased from Dec. 2021 (97 Mil) to Mar. Services, IT, Quality & Regulatory Affairs Steven R. Pacelli, Exec. DexCom Inc. has a dividend yield of -% with a dividend per share of $-and a payout ratio of -%. Mr. Abbey owns over 378 units of DexCom stock worth over $282,758 and over the last 4 years he sold DXCM stock worth over $9,653,883. DexCom's shares outstanding for the quarter that ended in Mar. In his past career he occupied the position of Senior Vice President-Quality . Most recently he sold 600 units of DXCM stock worth $253,764 on 4 March 2022. . San Diego, California 92121. DEXCOM INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Dexcom, headquartered in San Diego, California, and established in 1999, is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time. Instruction 1(b). Presently, Donald M. Abbey is Executive VP-Quality & Regulatory Affairs at DexCom, Inc. Mr. Abbey is also on the board of ICU Medical, Inc. Donald M. Abbey, Exec. Search. Unternehmensprofil. The Registered Agent on file for this company is Corporation Service Company and is located at 1003 Bishop Street Suite 1600 Pauahi Tower, Honolulu, HI 96813. Chad Patterson (Sold 2 186 shares of value $1 036 387 ), Donald Abbey (Sold 1 263 shares of value $683 747 ), Jake Leach (Sold 24 018 shares of value $9 671 973 ), Jay S. Skyler (Sold 20 000 shares of value $8 527 404 ), Jereme M. Sylvain . Marktwert / Umsatz 2023. Dexcom, Inc. is a Louisiana Business Corporation (Non-) filed On September 20, 2010. DEXCOM INC: 03/08/2022 1,180 406.06 Sell No DEXCOM INC: 03/08/2022 . Executive VP, Quality & Regulatory Affairs @dexcom.com Abbey Donald: 1,248: 541.3600 4,992 135.3400 675,617 2021-09-09: Abbey Donald: 15 . Services, IT, Quality & Regulatory Affairs Steven R. Pacelli, Exec. . DexCom Inc. company facts, information and financial ratios from MarketWatch. Abbey Donald (Last) (First) (Middle) 6340 SEQUENCE DRIVE (Street) SAN DIEGO: CA: 92121 (City) (State) (Zip) 2. Get Your 7-Day Free Trial! Dexcom has 3,900 employees, of which 32 are in a leadership position. ABBEY DONALD . This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. Chairman, President & Chief Executive Officer. Learn more about the sector, industry, classification, employee size, and executives of DXCM on MSN Money. Kevin has made over 70 trades of the Dexcom Inc stock since 2012, according to the Form 4 filled with the SEC. VP & MD of Dexcom Ventures Andrew K. Balo, Company profile for DexCom Inc. including key executives, insider trading, ownership, revenue and average growth rates. SVP, Chief Information Officer. EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 5,566 shares of DXCM on 03/10/2021 at an average price of $362.92 a share. Learn more about DXCM's sector, industry, classification, workforce size and executives on MSN Money. Wallmine is a radically better financial terminal. Relationship of Reporting Person(s) to Issuer . Directory of Profiled Business People: Donald Abbey Abarza prieto, Catherine - Abdallah, Serena > Abbett, Shelly - Abbey, Flora > Abbey, Donald - Abbey, Donna > Abbey, Donald 14 Contacts Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. | 2 Juni 2022 Issuer Name and Ticker or Trading Symbol DEXCOM INC [ DXCM] 5. EVP, Regulatory Strategy . Don has 30 . VP of Global Bus. DexCom, Inc. is a medical device company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. The last quarter saw substantial insider selling of DexCom shares. Insiders at DexCom Have Sold Stock Recently. Streubesitz. The company's filing status is listed as Active and its File Number is 73170 F1. Subscribe to our emails. Mr. Donald Abbey Executive Vice President, Global Business Services, IT, Quality and Regulatory Affairs Age: 55 Since: 2017. Donald M. Abbey is on the board of ICU Medical, Inc. and Executive VP-IT, Quality & Regulatory Affairs at DexCom, Inc. . Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Sector Health Care/Life Sciences. Dexcom Leadership. VP of Global Bus. and amended effective May 11, 2020. DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). EVP, Quality and Regulatory Affairs. The company offers its systems for use by people with .